Search > Hyperthyroidism
My employer runs this trial

IMVT-1402 for Graves' Disease

Enrolling by invitation at 88 trial locations
CS
Overseen ByCentral Study Contact
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Immunovant Sciences GmbH
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a long-term extension study that will rollover participants completing feeder studies IMVT-1402-2502 (NCT06727604) or IMVT-1402-2503 (NCT07018323) to evaluate the efficacy and safety of IMVT-1402 in adult participants with GD. Eligible participants will be assigned to 1 of 3 study groups (Groups A, B and C) based on their GD status at the completion of their respective feeder study.

Are You a Good Fit for This Trial?

Inclusion Criteria

I completed Study IMVT-1402-2502 or IMVT-1402-2503.
I meet other specific requirements listed in the study details.

What Are the Treatments Tested in This Trial?

Interventions

  • IMVT-1402

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Active Control

Group I: Group AExperimental Treatment1 Intervention
Group II: Group BActive Control1 Intervention
Group III: Group CActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Immunovant Sciences GmbH

Lead Sponsor

Trials
12
Recruited
1,400+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.